SEATTLE, March 5, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device® (ISDD®) technology, today announced groundbreaking new findings from an in-vitro study demonstrating that the Steripath® ISDD may improve the accuracy of blood...
Read More Details
Finally We wish PressBee provided you with enough information of ( New Study Demonstrates Potential for Enhanced Accuracy of Blood Cultures with Steripath® Initial Specimen Diversion Device® (ISDD®) for Central Line Draws )
Also on site :
- Heavy clashes erupt in southern Syria
- ‘I just had a sip,’ says driver drinking beer behind wheel before failing breathalyser
- US ‘reconsidering’ funding Ukraine – White House